Sam Gandy is a professor in Alzheimer’s Disease research, neurology, and psychiatry at Icahn School of Medicine, and director of the Center for Cognitive Health and NFL Neurological Care Center at Mount Sinai Health System. He and his team discovered the first drugs that could lower formation of amyloid, a protein that clogs the brain in Alzheimer’s patients, and he confirmed the first neuroimaging diagnosis of CTE in a living football player. A recipient of NIH funding for his amyloid metabolism research since 1986, Gandy has chaired the Alzheimer’s Association’s National Medical and Scientific Advisory Board and is a member of the Cure Alzheimer’s Fund Research Consortium. (Festival Underwriter Presenter)
Previously
Whether they remain free of diagnosable disease or become afflicted by dementia, our brains inevitably change as we grow older. Our cells degenerate, we forget names, and we t...